Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1947 1
1950 3
1988 1
1990 4
1991 1
1992 2
1997 6
1998 4
1999 5
2000 3
2001 1
2003 1
2004 1
2005 1
2006 1
2007 1
2008 3
2009 3
2010 4
2011 3
2012 2
2013 6
2014 3
2015 1
2016 1
2017 2
2018 3
2019 3
2020 4
2021 12
2022 11
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group. Sandborn WJ, et al. N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617. N Engl J Med. 2021. PMID: 34587385 Clinical Trial.
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, Blank MA, Johanns J, Gao LL, Miao Y, Adedokun OJ, Sands BE, Hanauer SB, Vermeire S, Targan S, Ghosh S, de Villiers WJ, Colombel JF, Tulassay Z, Seidler U, Salzberg BA, Desreumaux P, Lee SD, Loftus EV Jr, Dieleman LA, Katz S, Rutgeerts P; UNITI–IM-UNITI Study Group. Feagan BG, et al. N Engl J Med. 2016 Nov 17;375(20):1946-1960. doi: 10.1056/NEJMoa1602773. N Engl J Med. 2016. PMID: 27959607 Free article. Clinical Trial.
Vedolizumab as induction and maintenance therapy for Crohn's disease.
Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A; GEMINI 2 Study Group. Sandborn WJ, et al. N Engl J Med. 2013 Aug 22;369(8):711-21. doi: 10.1056/NEJMoa1215739. N Engl J Med. 2013. PMID: 23964933 Free article. Clinical Trial.
Isoniazid-related hepatitis.
Vasudeva R, Woods B. Vasudeva R, et al. Dig Dis. 1997 Nov-Dec;15(6):357-67. doi: 10.1159/000171611. Dig Dis. 1997. PMID: 9439900 Review.
Collagenous colitis.
Vasudeva R. Vasudeva R. J S C Med Assoc. 1990 Feb;86(2):115-6. J S C Med Assoc. 1990. PMID: 2308291 No abstract available.
Cardiac POCUS: Another Tool in the Armory.
Vasudeva R, Challa A, Chaaban N, Shah H, Brumfield E, Duran B, Vindhyal M. Vasudeva R, et al. Kans J Med. 2023 Jul 25;16:172-175. doi: 10.17161/kjm.vol16.19802. eCollection 2023. Kans J Med. 2023. PMID: 37539370 Free PMC article.
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Sandborn WJ, Gasink C, Gao LL, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P, Ghosh S, de Villiers WJ, Panaccione R, Greenberg G, Schreiber S, Lichtiger S, Feagan BG; CERTIFI Study Group. Sandborn WJ, et al. N Engl J Med. 2012 Oct 18;367(16):1519-28. doi: 10.1056/NEJMoa1203572. N Engl J Med. 2012. PMID: 23075178 Free article. Clinical Trial.
Social vulnerability and COVID-19: An analysis of CDC data.
Al Rifai M, Jain V, Khan SU, Nasir K, Zhu D, Vasudeva R, Lavie CJ, Dodani S, Petersen LA, Virani SS. Al Rifai M, et al. Among authors: vasudeva r. Prog Cardiovasc Dis. 2022 Jul-Aug;73:91-93. doi: 10.1016/j.pcad.2021.09.006. Epub 2021 Sep 22. Prog Cardiovasc Dis. 2022. PMID: 34560121 Free PMC article. No abstract available.
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Vermeire S, Lakatos PL, Ritter T, Hanauer S, Bressler B, Khanna R, Isaacs K, Shah S, Kadva A, Tyrrell H, Oh YS, Tole S, Chai A, Pulley J, Eden C, Zhang W, Feagan BG; LAUREL Study Group. Vermeire S, et al. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):28-37. doi: 10.1016/S2468-1253(21)00295-8. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798037 Clinical Trial.
103 results